Alvogen

Alvogen was founded by Icelandic entrepreneur Róbert Wessman, who stepped down from his position as CEO of another generics company, Actavis, in order to found the company.[https://www.fiercebiotech.com/biotech/wessman-steps-down-as-actavis-ceo Wessman steps down as Actavis CEO]{{cite book|url=https://books.google.com/books?id=PJXBAgAAQBAJ&pg=PA15|title=Worthless, Impossible and Stupid: How Contrarian Entrepreneurs Create and Capture Extraordinary Value|first=Daniel|last=Isenberg|date=9 July 2013|publisher=Harvard Business Review Press|via=Google Books|isbn=9781422186985}}

The first and still a central component of Alvogen is the 130-year old Norwich Pharmaceuticals, which was acquired by Wessman and his investors as a large-scale and certified manufacturing facility. From the early- to mid-2010s, Alvogen expanded rapidly through acquisitions.Isenberg, Daniel, et al., [https://www.hbs.edu/faculty/Pages/item.aspx?num=54868 "Alvogen: Scaling Entrepreneurship,"] Harvard Business School case study, 4 August 2018. In Central and Eastern Europe it acquired companies and portfolios including Labormed in Romania.[https://www.thepharmaletter.com/generics/alvogen-acquires-labormed-pharmaceuticals "Alvogen acquires Labormed Pharmaceuticals,"] The Pharmaletter, 1 February 2013.[https://www.biospace.com/alvogen-announces-acquisition-to-expand-russian-business "Alvogen Announces Acquisition To Expand Russian Business,"] BioSpace, 15 August 2017. In East Asia, it acquired South Korea firms Kunwha[https://www.thepharmaletter.com/generics/alvogen-to-acquire-majority-stake-in-kunwha-pharma-alliance-buys-opus "Alvogen to acquire majority stake in Kunwha Pharma,"] The Pharmaletter, 12 October 2012. and DreamPharma,[https://www.fiercepharma.com/manufacturing/alvogen-acquires-korean-dream-pharma-for-us-187-million "Alvogen Acquires Korean Dream Pharma for US$ 187 Million,"] Fierce Pharma, 7 August 2014. and then operated them under the umbrella of [https://www.lotuspharm.com/ Lotus Pharmaceuticals], a Taiwan company it purchased in 2014 and which is listed on the Taipei Stock Exchange (1795.TT).Company press release, [https://www.businesswire.com/news/home/20140116006005/en/Alvogen-and-Lotus-Pharmaceuticals-Merge-Asian-Operations-to-Create-Compelling-Platform-for-International-Growth "Alvogen and Lotus Pharmaceuticals Merge Asian Operations to Create Compelling Platform for International Growth,"] Businesswire, 16 January 2014. In 2016, Alvogen expanded its US footprint with the acquisition of County Line Pharmaceuticals.[https://archive.jsonline.com/business/county-line-pharmaceuticals-to-be-acquired-by-alvogen-for-300-million-b99683979z1-371453091.html/ "County Line Pharmaceuticals to be acquired by Alvogen for $300 million,"] Milwaukee Journal Sentinel, 8 March 2016 The history of the growth of Alvogen is the subject of a Harvard Business School case study published in 2018.Isenberg et al., op. cit.

In 2017, Alvogen was valued at $4 billion and had 2800 employees spread over thirty-five countries.{{cite web|url=https://www.bloomberg.com/news/articles/2017-09-26/cvc-is-said-to-explore-options-for-4-billion-drugmaker-alvogen|title=CVC to Explore Options for $4 Billion Drugmaker Alvogen|date=26 September 2017|via=www.bloomberg.com}} Beginning in 2019, the company began to spin off its international operations and divisions, some of which had grown large enough to become standalone companies, and to focus on its US operations. Alvogen's Central and Eastern Europe operations were sold to Zentiva in 2019.Press release, [https://www.prnewswire.com/in/news-releases/zentiva-extends-commercial-footprint-by-completing-acquisition-of-cee-business-from-alvogen-895530486.html "Zentiva Extends Commercial Footprint By Completing Acquisition of CEE Business From Alvogen,"] PR Newswire, 7 April 2020. In 2021, it spun off Lotus to a consortium of Innobic and Wessman's investment fund [https://www.aztiq.com/ Aztiq], which also bought Alvogen's Malta-based B2B licensing division [https://www.adalvo.com/ Adalvo].[https://www.pbiforum.net/mag/featured/aztiq-and-innobic-acquire-alvogens-shares-in-lotus-and-adalvo-in-475m-deal/ "Aztiq and Innobic acquire Alvogen’s shares in Lotus and Adalvo in $475m deal,"] Pharma Business International, 1 December 2021 As of early 2025, Wessman was chairman of Alvogen, as well as of Lotus and Adalvo.See company and Wessman's personal websites: https://www.alvogen.com/company/meet-the-chairman, https://www.lotuspharm.com/robert-wessman, https://www.robertwessman.com/operation

Alvogen was also the original investor in [https://www.alvotech.com/ Alvotech], a company founded by Wessman in 2013 that researches and manufactures biosimilars. Alvotech is based in Reykjavik and has four research and production sites across Europe and one in India.https://www.alvotech.com/office-locations It is listed on Nasdaq (ticker: [https://www.nasdaq.com/market-activity/stocks/alvo ALVO]) and also trades on [https://www.nasdaq.com/european-market-activity/shares/alvo?id=ICE260316 Nasdaq Iceland]. As of early 2025, it has several products approved in the US and Europe and markets globally through partnerships.https://www.alvotech.com/pipeline

On its website, Alvogen lists dozens of [https://www.alvogen.com/product-catalog-usa products it currently offers] on the US market. It specializes in products that are either difficult to make or are injectable or inhaled.https://www.alvogen.com/company It's injectables business is called [https://www.almaject.com/ Almaject].

{{reflist}}

• [https://alvogen.com/ Official website]

{{Biotechnology industry in South Korea}}

Category:Pharmaceutical companies based in New Jersey

Category:Pharmaceutical companies established in 2009

Category:Pharmaceutical companies of South Korea

Category:Companies listed on the Korea Exchange

Category:Temasek Holdings

Category:CVC Capital Partners companies